Asthma

Chronic comorbid conditions are common in adult asthma patients, and these patients need ongoing support and encouragement from health care providers including pharmacists.

A new study finds that in children whose mothers had asthma attacks during pregnancy were at increased risk of a range of health problems.

Asthma patients who received tailored counseling from community pharmacists over a 6-month period were 3 times as likely as those in a control group to have their asthma under control.

A comprehensive new review explores approaches to classifying and treating severe asthma, which affects 5% to 10% of asthma patients.

Non-cardioselective beta-blockers appear to pose the greatest risk to patients with asthma or COPD.

Urban elementary school students with poorly controlled asthma tend to produce poorer schoolwork and sleep less well than those whose asthma is well-controlled.

Just 17% of children who had lived in the United States for up to 2 years had asthma or allergies, compared with 27% of those who had lived in the country for 10 years or longer.

The association between use of analgesics in infancy and increased likelihood of developing asthma may actually be due to respiratory infections that prompt analgesic use, a new study indicates.

This potentially serious condition is only partially understood, and its triad of symptoms often goes unrecognized.

Pharmacists are often the first clinicians to see cases of occupational dermatitis, rhinitis, and asthma.

Anxiety and depression may have a negative impact on self-management of asthma.

Pharmacists can increase regimen compliance by taking the time to educate patients.

Patients who understand environmental triggers are better able to avoid asthma attacks.

Patients who understand environmental triggers are better able to avoid asthma attacks.

The results of a study analyzing patterns of asthma medication prescription from 1994 to 2009 suggest that awareness of the importance of controlling asthma during pregnancy needs to be improved.

An inhaler from Nephron Pharmaceuticals has brought an OTC asthma medication back to retail stores, filling the gap left when Primatene Mist was discontinued in 2011.

The only OTC asthma inhaler was pulled from the market at the end of 2011 due to environmental concerns, but its manufacturer is trying to bring it back.

There is no evidence that consuming peanuts and tree nuts during pregnancy increases the risk of childhood asthma and allergies, a study suggests.